The current PE ratio of BAX can't be determined, as the TTM EPS of -$1.27 is negative. The last recorded PE ratio for Baxter International was 180.81 in September 2024.
The average historical PE ratio of Baxter International for the last ten years is 31.87. In the past ten years, BAX's PE ratio was at its highest in the Sep 2024 quarter at 180.81, when the stock price was $37.97 and the EPS was $0.21. The lowest value was in the Dec 2016 quarter, when it reached 4.88 with a price of $44.34 and an EPS of $9.09.
Maximum annual increase: 1,093.24% in 2017
Maximum annual decrease: -77.23% in 2016
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | N/A | N/A | $29.16 | -$1.27 |
2023 | 7.36 | N/A | $38.66 | $5.25 |
2022 | N/A | N/A | $50.97 | -$4.83 |
2021 | 33.53 | -9.33% | $85.84 | $2.56 |
2020 | 36.98 | -12.89% | $80.24 | $2.17 |
2019 | 42.45 | 87% | $83.62 | $1.97 |
2018 | 22.7 | -61.02% | $65.82 | $2.9 |
2017 | 58.23 | 1,093.24% | $64.64 | $1.11 |
2016 | 4.88 | -77.23% | $44.34 | $9.09 |
2015 | 21.43 | 34.78% | $38.15 | $1.78 |
2014 | 15.9 | -15.43% | $73.29 | $4.61 |
2013 | 18.8 | 18.99% | $69.55 | $3.7 |
2012 | 15.8 | 24.9% | $66.66 | $4.22 |
2011 | 12.65 | -39.76% | $49.48 | $3.91 |
2010 | 21 | 29.87% | $50.62 | $2.41 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | N/A | N/A | $29.16 | -$1.27 |
Sep 2024 | 180.81 | 2,543.42% | $37.97 | $0.21 |
Jun 2024 | 6.84 | -16.28% | $33.45 | $4.89 |
Mar 2024 | 8.17 | 11.01% | $42.74 | $5.23 |
Dec 2023 | 7.36 | 0% | $38.66 | $5.25 |
Sep 2023 | 7.36 | N/A | $37.74 | $5.13 |
Jun 2023 | N/A | N/A | $45.56 | -$5.65 |
Mar 2023 | N/A | N/A | $40.56 | -$4.87 |
Dec 2022 | N/A | N/A | $50.97 | -$4.83 |
Sep 2022 | N/A | N/A | $53.86 | -$4.71 |
Jun 2022 | 31.8 | -13.47% | $64.23 | $2.02 |
Mar 2022 | 36.75 | 9.6% | $77.54 | $2.11 |
Dec 2021 | 33.53 | 0.87% | $85.84 | $2.56 |
Sep 2021 | 33.24 | -8.33% | $80.43 | $2.42 |
Jun 2021 | 36.26 | -9.28% | $80.5 | $2.22 |
Stock name | PE ratio | Market cap |
---|---|---|
HALO Halozyme Therapeutics Inc | 17.56 | $7.57B |
CAH Cardinal Health Inc | 23.04 | $30B |
MDT Medtronic plc | 28.18 | $119.64B |
TMO Thermo Fisher Scientific Inc | 31.01 | $193.99B |
BDX Becton Dickinson & Co | 37.74 | $64.58B |
SYK Stryker Corp | 46.47 | $139.39B |
BSX Boston Scientific Corp | 75.81 | $140.97B |
OMI Owens & Minor Inc | N/A | $736.94M |
ICUI Icu Medical Inc | N/A | $3.41B |
BAX Baxter International Inc | N/A | $18.34B |
The current price to earnings ratio of BAX can't be calculated, as its EPS of -$1.27 is negative.
As an average over the last 3 years, BAX stock has a PE ratio of 39.87.
As an average over the last 5 years, BAX stock has a PE ratio of 39.56.
The highest quarterly PE ratio in the last ten years has been 180.81 and it was in the Sep 2024 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.